Beatriz Arns, Guilherme Geraldo Lovato Sório, Tarsila Vieceli, Dariane Pereira, Andrea Souza, Priscila Wink, Dariane Pereira, Julia Hoefel Paes, Leonardo David, Fernanda Barboza, Stella Hickmann, Gustavo Alves, Antônio Cândido Santos, Anelise da Rosa, Marcelle Alves, Cibele Magagnin, Eduardo Gomes, Alexandre Prehn Zavascki, Maria Helena Rigatto
OBJECTIVES: This study aimed to evaluate the clinical and microbiological risk factors associated with mortality in patients treated with ceftazidime-avibactam for carbapenem-resistant gram-negative bacterial infections. METHODS: This multicentric prospective cohort study included hospitalized adult patients with a microbiologically confirmed infection treated with ceftazidime-avibactam for ≥48 hours. The clinical and microbiological risk factors for 30-day mortality were evaluated using a Cox regression model...
February 9, 2024: Journal of Global Antimicrobial Resistance